SK151395A3 - Heterocyclic amide compounds, preparation method thereof, pharmaceutical compositions and their use - Google Patents

Heterocyclic amide compounds, preparation method thereof, pharmaceutical compositions and their use Download PDF

Info

Publication number
SK151395A3
SK151395A3 SK1513-95A SK151395A SK151395A3 SK 151395 A3 SK151395 A3 SK 151395A3 SK 151395 A SK151395 A SK 151395A SK 151395 A3 SK151395 A3 SK 151395A3
Authority
SK
Slovakia
Prior art keywords
formula
heterocyclic amides
mmol
alkyl
radical
Prior art date
Application number
SK1513-95A
Other languages
English (en)
Slovak (sk)
Inventor
Peter Esch
Robertson Towart
Franz Rovenszky
Original Assignee
Hafslund Nycomed Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hafslund Nycomed Pharma filed Critical Hafslund Nycomed Pharma
Publication of SK151395A3 publication Critical patent/SK151395A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/121,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/1251,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C07D285/135Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/44Acylated amino or imino radicals
    • C07D277/46Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/36Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
SK1513-95A 1994-12-05 1995-11-30 Heterocyclic amide compounds, preparation method thereof, pharmaceutical compositions and their use SK151395A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0225294A AT402926B (de) 1994-12-05 1994-12-05 Heterocyclische amide, verfahren zu ihrer herstellung und verwendung

Publications (1)

Publication Number Publication Date
SK151395A3 true SK151395A3 (en) 1996-06-05

Family

ID=3530873

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1513-95A SK151395A3 (en) 1994-12-05 1995-11-30 Heterocyclic amide compounds, preparation method thereof, pharmaceutical compositions and their use

Country Status (15)

Country Link
US (1) US5627198A (no)
EP (1) EP0716087A1 (no)
JP (1) JPH08225553A (no)
CN (1) CN1132204A (no)
AT (1) AT402926B (no)
AU (1) AU4021595A (no)
CA (1) CA2164375A1 (no)
CZ (1) CZ321695A3 (no)
FI (1) FI955818A (no)
HU (1) HUT75064A (no)
IL (1) IL116245A0 (no)
NO (1) NO954913L (no)
NZ (1) NZ280589A (no)
SK (1) SK151395A3 (no)
ZA (1) ZA9510305B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6407124B1 (en) 1998-06-18 2002-06-18 Bristol-Myers Squibb Company Carbon substituted aminothiazole inhibitors of cyclin dependent kinases
TWI271402B (en) * 2002-10-15 2007-01-21 Tanabe Seiyaku Co Large conductance calcium-activated K channel opener
DK2528621T3 (da) 2010-01-27 2017-01-02 Glaxosmithkline Biologicals Sa Modificerede tuberkuloseantigener
CN110117263B (zh) * 2019-06-11 2020-12-25 湖南中医药大学 2-氨基-5-酰基噻唑衍生物及其合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3051M (fr) * 1963-11-15 1965-01-04 Bruneau & Cie Lab Médicament a base de dérivé de thiadiazol.
TW205041B (no) * 1989-08-07 1993-05-01 Fujisawa Pharmaceutical Co
GB9214120D0 (en) * 1991-07-25 1992-08-12 Ici Plc Therapeutic amides
GB9305295D0 (en) * 1993-03-15 1993-05-05 Zeneca Ltd Therapeutic compounds

Also Published As

Publication number Publication date
HU9503466D0 (en) 1996-01-29
US5627198A (en) 1997-05-06
ZA9510305B (en) 1996-06-11
NO954913D0 (no) 1995-12-04
IL116245A0 (en) 1996-03-31
ATA225294A (de) 1997-02-15
NZ280589A (en) 1996-08-27
CN1132204A (zh) 1996-10-02
EP0716087A1 (de) 1996-06-12
JPH08225553A (ja) 1996-09-03
AU4021595A (en) 1996-06-13
FI955818A0 (fi) 1995-12-04
NO954913L (no) 1996-06-06
FI955818A (fi) 1996-06-06
AT402926B (de) 1997-09-25
HUT75064A (en) 1997-03-28
CA2164375A1 (en) 1996-06-06
CZ321695A3 (en) 1996-06-12

Similar Documents

Publication Publication Date Title
FI112940B (fi) Menetelmä terapeuttisesti käyttökelpoisen amidin valmistamiseksi
AU2009209885B2 (en) Thiazole derivative and use thereof as VAP-1 inhibitor
JP5225076B2 (ja) チアゾール環を含むカルボン酸誘導体の医薬用途
AU2002334817B2 (en) Thiopene- and Thiazolesulfonamides as Antineoplastic Agents
MX2007016319A (es) Derivados de n-(piridin-2-il)-sulfonamida.
KR20080002832A (ko) 보체 매개성 질병 및 이상을 치료하기 위한 신규한 티오펜설폭시민
RU2299202C2 (ru) N-фениларилсульфонамид, фармацевтическая композиция, содержащая указанное соединение в качестве активного ингредиента, соединение, являющееся промежуточным в синтезе указанного соединения, и способ его получения
AU2002334817A1 (en) Thiopene- and Thiazolesulfonamides as Antineoplastic Agents
NO162237B (no) Analogifremgangsm te for fremstilling av terapeutisk aktive heterocykliske forbindelser.
WO1999062892A1 (en) Aminoazole compounds
CA2080949A1 (en) Therapeutic agents
JP3723589B2 (ja) イソオキサゾール誘導体
US10221147B2 (en) Heterocyclic compounds with working memory enhancing activity
SK151395A3 (en) Heterocyclic amide compounds, preparation method thereof, pharmaceutical compositions and their use
CN108383828A (zh) 作为趋化因子受体调节剂的新的1,2-双-磺酰胺衍生物
EP0180500A1 (fr) Dérivés de thiéno et furo - [2,3-c]pyrroles, procédés de préparation et médicaments les contenant
CZ281710B6 (cs) Nitroxyalkylamidové deriváty, způsob výroby a farmaceutické prostředky s jejich obsahem
EP2985279B1 (en) Heterocyclic compounds with working memory enhancing activity
CA2063865A1 (en) 2-(substituted imino)-thiazolidines and process for the preparation thereof
DE19506652A1 (de) Heterocyclische Amide, Verfahren zu ihrer Herstellung und ihre Verwendung
JPH05503096A (ja) 新規のチアゾール誘導体
PL171991B1 (pl) Sposób wytwarzania nowych amidów
WO2001094326A1 (fr) Nouveaux derives de thiazolidinedione et utilisation de ceux-ci comme medicament
JPH0812659A (ja) チアゾール誘導体及びこれを含有する医薬製剤